Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 815 of 1,261
  1. US 8728532

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted May 20, 2014 · Expires May 15, 2034

    granted
  2. US 8728757

    Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted
  3. US 8728806

    Methods and compositions related to Th-1 dendritic cells

    The Board of Regents of the University of Texas System · Granted May 20, 2014 · Expires May 15, 2034

    granted
  4. US 8729027

    Therapeutic agent for fibromyalgia containing etanercept

    AXIS · Granted May 20, 2014 · Expires May 15, 2034

    granted
  5. US 8729028

    Noggin-derived peptide and use thereof

    CAREGEN CO., LTD. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  6. US 8729037

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  7. US 8729047

    Compositions for inhibiting redox-sensitive GTPases

    The Board of Regents of the University of Texas System · Granted May 20, 2014 · Expires May 15, 2034

    granted
  8. US 8729087

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  9. US 8729081

    Compositions and methods for treating alcohol use disorders, pain and other diseases

    VM Discovery Inc. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  10. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

    granted
  11. US 8729100

    Method and composition for treating an alpha adrenoceptor-mediated condition

    VANDA PHARMACEUTICALS INC. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  12. US 8729115

    Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases

    CARDIOLYNX AG · Granted May 20, 2014 · Expires May 15, 2034

    granted
  13. US 8729248

    Sperm-specific cation channel, CATSPER2, and uses therefor

    The Board of Regents of the University of Texas System · Granted May 20, 2014 · Expires May 15, 2034

    granted
  14. US 8729305

    Process for the preparation of and crystalline forms of optical enantiomers of modafinil

    Teva Sante · Granted May 20, 2014 · Expires May 15, 2034

    granted
  15. US 8722132

    Application of a coating on a medical device

    ATRIUM MEDICAL CORPORATION · Granted May 13, 2014 · Expires May 8, 2034

    granted
  16. US 8721620

    Swallowable drug delivery device and methods of drug delivery

    Rani Therapeutics, LLC · Granted May 13, 2014 · Expires May 8, 2034

    granted
  17. US 8722662

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted May 13, 2014 · Expires May 8, 2034

    granted
  18. US 8722660

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 13, 2014 · Expires May 8, 2034

    granted
  19. US 8722653

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 13, 2014 · Expires May 8, 2034

    granted
  20. US 8722646

    High concentration chitosan-nucleic acid polyplex compositions

    ENGENE, INC. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  21. US 8722082

    Lipids and compositions for the delivery of therapeutics

    Tekmira Pharmaceuticals Corporation · Granted May 13, 2014 · Expires May 8, 2034

    granted
  22. US 8722645

    Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  23. US 8722628

    Autophagy-inducing peptide

    The Board of Regents of the University of Texas System · Granted May 13, 2014 · Expires May 8, 2034

    granted
  24. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    The United States of America as represented by the Secretary of the Army · Granted May 13, 2014 · Expires May 8, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.